Diastika Biotekindo Tbk. vs Brigit Biofarmaka Teknologi Tbk. — how do they compare? Diastika Biotekindo Tbk. trades at Rp132 (market cap 534.73B, 418.3K 24h volume), while Brigit Biofarmaka Teknologi Tbk. trades at Rp242 (market cap 164.65B, 187.4K 24h volume). The key difference: Diastika Biotekindo Tbk. is far larger — about 3.2× Brigit Biofarmaka Teknologi Tbk.'s market cap, and Diastika Biotekindo Tbk. is more actively traded (418.3K versus 187.4K). Which is the better fit depends on your goals.
| CHEK | OBAT | |
|---|---|---|
Market Cap | 534.73B | 164.65B |
Volume | 418.3K | 187.4K |
Lot | 4.18K | 1.87K |
Turnover | 54.5M | 44.35M |
Average Price | 130.28 | 236.67 |
Value | 54.5M | 44.35M |
Indicative Equilibrium Price | 132 | 242 |
Indicative Equilibrium Volume | 20 | 500 |
Trailing returns across standard periods
Latest headlines on both assets
PT Diastika Biotekindo Tbk. (The Company) was established in Jakarta based on Deed No. 33 dated July 20, 1989 made before Mrs. Sitti Marjami Soepangat, SH. notary in Jakarta. The Company started its commercial activities in years 1986. The parent entity as well as the ultimate parent entity of the Company is PT Optel Investama Mulia.
Read more on CHEK →PT. Brigit Biofarmaka Teknologi Tbk. (the Company) was established based on Notarial Deed No. 103 dated December 14, 2015 of Yoerista Arya Megasari, S.H., M.Kn., Notary in Sukoharjo. The company starts production commercially in 2018.
Read more on OBAT →